Chicoric acid is an antioxidant molecule that stimulates AMP kinase pathway in L6 myotubes and extends lifespan in Caenorhabditis elegans

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Schlernitzauer, Audrey ^a,b,c   Oiry, Catherine ^b,c   Hamad, Raphael ^c   Galas, Simon ^c   Cortade, Fabienne ^a,c   Chabi, Béatrice ^a,c   Casas, François ^a,c   Pessemesse, Laurence ^a,c   Fouret, Gilles ^a,c   Feillet Coudray, Christine ^a,c   Cros, Gérard ^b,c   Cabello, Gérard ^a,c   Magous, Richard ^b,c   Wrutniak Cabello, Chantal ^a,c  

^a University of Montpellier   (France)

^b UNIVERSITÉ DE MONTPELLIER   (France)

^c UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; CICHORIC ACID; CITRATE SYNTHASE; CYTOCHROME C OXIDASE; EPIGALLOCATECHIN GALLATE; GLUTATHIONE PEROXIDASE; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN KINASE B; QUERCETIN; REACTIVE OXYGEN METABOLITE; SUCCINATE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE DISMUTASE;

AGING; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; BIOGENESIS; CAENORHABDITIS ELEGANS; CELL CULTURE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; LIFESPAN; LONGEVITY; MITOCHONDRION; MYOTUBE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; UPREGULATION;

ADENYLATE KINASE; ANIMALS; ANTIOXIDANTS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CAFFEIC ACIDS; CITRATE (SI)-SYNTHASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LONGEVITY; MUSCLE FIBERS, SKELETAL; OXIDOREDUCTASES; SUCCINATES; TRANSCRIPTION FACTORS;

EID: 84892949233     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078788     Document Type: Article

References (74)

1. Beale EG (2008) 59-AMP-activated protein kinase signaling in Caenorhabditis elegans. Exp Biol Med (Maywood) 233: 12-20.
2. Towler MC, Hardie DG (2007) AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 100: 328-34.
3. Hardie DG (2004) The AMP-activated protein kinase pathway - new players upstream and downstream. J Cell Sci 117: 5479-5487.
4. Kemp BE, Stapleton D, Campbell DJ, Chen Z, Murthy S, et al. (2003) AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans 31: 162-168. (Pubitemid 36241420)
5. Carling D, Zammit VA, Hardie DG (1987) A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis. FEBS Lett 223: 217-222.
6. Holloway GP, Bonen A, Spriet LL (2009) Regulation of skeletal muscle mitochondrial fatty acid metabolism in lean and obese individuals. Am J Clin Nutr 89: 455S-62S.
7. Kukidome D, Nishikawa T, Sonoda K, Imoto K, Fujisawa K, et al. (2006) Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes 55: 120-127. (Pubitemid 43343306)
8. Valle I, Alvarez-Barrientos A, Arza E, Lamas S, Monsalve M (2005) PGC-1alpha regulates the mitochondrial antioxidant defence system in vascular endothelial cells. Cardiovasc Res 66: 562-573. (Pubitemid 40725768)
9. Lee Y, Park O (2010) Regulation of mutual inhibitory activities between AMPK and Akt with quercetin in MCF-7 breast cancer cells. Oncol Rep 24: 1493-7.
10. Lee Y, Lee W, Kim G, Park O (2010) Anthocyanins are novel AMPKα1 stimulators that suppress tumor growth by inhibiting mTOR phosphorylation. Oncol Rep 24: 1471-17.
11. King TD, Song L, Jope RS (2006) AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3. Biochem Pharmacol 71: 1637-1647.
12. Curtis R, O'Connor G, DiStefano PS (2006) Aging networks in Caenorhabditis elegans: AMP-activated protein kinase (aak-2) links multiple aging and metabolism pathways. Aging Cell 5: 119-126. (Pubitemid 44056503)
13. Büchter C, Ackermann D, Havermann S, Honnen S, Chovolou Y, et al. (2013) Myricetin-mediated lifespan extension in Caenorhabditis elegans is modulated by DAF-16. Int J Mol Sci 14: 11895-914.
14. Cabreiro F, Au C, Leung KY, Vergara-Irigaray N, Cochemé HM, et al. (2013) Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell 153: 228-39.
15. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, et al. (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300: 1140-2. (Pubitemid 36583097)
16. Jornayvaz FR, Shulman GI (2010) Regulation of mitochondrial biogenesis. Essays Biochem 47: 69-84.
17. Hegarty BD, Turner N, Cooney GJ, Kraegen EW (2009) Insulin resistance and fuel homeostasis: the role of AMP-activated protein kinase. Acta Physiol (Oxf) 196: 129-145.
18. Luo Z, Saha AK, Xiang X, Ruderman NB (2005) AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci 26: 69-76. (Pubitemid 40170168)
19. Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, et al. (2000) Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49: 2063-2069.
20. Yu X, McCorkle S, Wang M, Lee Y, Li J, et al. (2004) Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition. Diabetologia 47: 2012-2021. (Pubitemid 40110213)
21. Pold R, Jensen LS, Jessen N, Buhl ES, Schmitz O, et al. (2005) Long-Term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes 54: 928-34. (Pubitemid 40446305)
22. Jung UJ, Lee M, Park YB, Jeon S, Choi M. (2006) Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice. J Pharmacol Exp Ther 318: 476-483. (Pubitemid 44061220)
23. Lee ES, Uhm K, Lee YM, Han M, Lee M, et al. (2007) CAPE (caffeic acid phenethyl ester) stimulates glucose uptake through AMPK (AMP-activated protein kinase) activation in skeletal muscle cells. Biochem Biophys Res Commun 361: 854-858. (Pubitemid 47263453)
24. Tousch D, Lajoix A, Hosy E, Azay-Milhau J, Ferrare K, et al. (2008) Chicoric acid, a new compound able to enhance insulin release and glucose uptake. Biochem Biophys Res Commun 377: 131-135.
25. Xiao H, Wang J, Yuan L, Xiao C, Wang Y, et al. (2013) Chicoric acid induces apoptosis in 3T3-L1 preadipocytes through ROS-mediated PI3K/Akt and MAPK signaling pathways. J Agric Food Chem 61: 1509-20.
26. Andary C, Ribes G, Tousch D, Azay-Milhau J, Lajoix AD (2007) Anti-diabetes composition containing chicoric acid and/or one of the metabolites thereof. Patent US 20110015140 A1; Patent EP2056802 B1.
27. Rustin P, Chretien D, Bourgeron T, Gérard B, Rötig A, et al. (1994) Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 228: 35-51. (Pubitemid 24231224)
28. Srere P (1969) Citrate synthase. Methods Enzymol 13: 3-11.
29. Flohé L, Günzler WA (1984) Assays of glutathione peroxidase. Methods Enzymol 105: 114-21.
30. Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47: 469-474.
31. Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77: 71-94.
32. Stiernagle T (2006) Maintenance of C. elegans. Wormbook 11: 1-11.
33. Mitchell DH, Stiles JW, Santelli J, Sanadi DR (1979) Synchronous growth and aging of Caenorhabditis elegans in the presence of fluorodeoxyuridine. J Gerontol 34: 28-36. (Pubitemid 9101693)
34. Scarpulla RC (2006) Nuclear control of respiratory gene expression in mammalian cells. J Cell Biochem 97: 673-683.
35. St-Pierre J, Lin J, Krauss S, Tarr PT, Yang R, et al. (2003) Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J Biol Chem 278: 26597-26603. (Pubitemid 36876804)
36. Kang C, Li Ji L (2012) Role of PGC-1a signaling in skeletal muscle health and disease. Ann N Y Acad Sci 1271: 110-7.
37. Kenyon C (2005) The plasticity of aging: insights from long-lived mutants. Cell 120: 449-460.
38. Ruderman N, Prentki M (2004) AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat Rev Drug Discov 3: 340-351. (Pubitemid 38499761)
39. Rudich A, Tirosh A, Potashnik R, Hemi R, Kanety H, et al. (1998) Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes 47: 1562-1569. (Pubitemid 28445343)
40. 2 in cells and thereby their biological state. Free Radic Biol Med 41: 1338-1350.
41. Shan X, Chi L, Ke Y, Luo C, Qian S, et al. (2007) Manganese superoxide dismutase protects mouse cortical neurons from chronic intermittent hypoxia-mediated oxidative damage. Neurobiol Dis 28: 206-215. (Pubitemid 47615459)
42. Shin SM, Cho IJ, Kim SG (2009) Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3β inhibition downstream of poly (ADP-ribose) polymerase-LKB1 pathway. Mol Pharmacol 76: 884-95.
43. Robb EL, Page MM, Wiens BE, Stuart JA (2008) Molecular mechanisms of oxidative stress resistance induced by resveratrol: specific and progressive induction of MnSOD. Biochem Biophys Res Commun 367: 406-412.
44. Lam TKT, Van de Werve G, Giacca A (2003) Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites. Am J Physiol Endocrinol Metab 284: E281-290. (Pubitemid 36120100)
45. Kraegen EW, Cooney GJ (2008) Free fatty acids and skeletal muscle insulin resistance. Curr Opin Lipidol 19: 235-241. (Pubitemid 351653560)
46. Viollet B, Foretz M, Guigas B, Horman S, Dentin R, et al. (2006) Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J Physiol 574: 41-53. (Pubitemid 43905795)
47. Roden M, Stingl H, Chandramouli V, Schumann WC, Hofer A, et al. (2000) Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabete. 49: 701-707. (Pubitemid 30339983)
48. Viollet B, Mounier R, Leclerc J, Yazigi A, Foretz M, et al. (2007) Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. Diabetes & Metabolism 33: 395-402. (Pubitemid 350218220)
49. Zhang Z, Li Q, Liang J, Dai X, Ding Y, et al. (2010) Epigallocatechin-3- O-gallate (EGCG) protects the insulin sensitivity in rat L6 muscle cells exposed to dexamethasone condition. Phytomedicine 17: 14-18.
50. Fink BD, O'Malley Y, Dake BL, Ross NC, Prisinzano TE, et al. (2009) Mitochondrial targeted coenzyme Q, superoxide, and fuel selectivity in endothelial cells. PLoS ONE 4: e4250.
51. Fogarty S, Hardie DG. (2010) Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim Biophys Acta 1804: 581-91.
52. Momcilovic M, Hong SP, Carlson M (2006) Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J Biol Chem 281: 25336-25343. (Pubitemid 44401921)
53. Russo GL, Russo M, Ungaro P (2013) AMP-activated protein kinase: a target for old drugs against diabetes and cancer. Biochem Pharmacol 86: 339-50.
54. Turner N, Li JY, Gosby A, To SW, Cheng Z, et al. (2008) Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes 57: 1414-8.
55. Pil Hwang Y, Gyun Kim H, Choi JH, Truong Do M, Tran TP, et al. (2013) 3-Caffeoyl, 4-dihydrocaffeoylquinic acid from Salicornia herbacea attenuates high glucose-induced hepatic lipogenesis in human HepG2 cells through activation of the liver kinase B1 and silent information regulator T1/AMPK-dependent pathway. Mol Nutr Food Res 57: 471-82.
56. Murase T, Misawa K, Haramizu S, Hase T (2009) Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway. Biochem Pharmacol 78: 78-84.
57. Scarpulla RC (2006) Nuclear control of respiratory gene expression in mammalian cells. J Cell Biochem 97: 673-683.
58. Csiszar A, Labinskyy N, Pinto JT, Ballabh P, Zhang H, et al. (2009) Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol 297: H13-H20.
59. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, et al. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1a. Cell 127: 1109-1122. (Pubitemid 44894520)
60. Mootha VK, Lindgren CM, Eriksson K, Subramanian A, Sihag S, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273. (Pubitemid 36792858)
61. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350: 664-671. (Pubitemid 38364625)
62. Lowell BB, Shulman GI (2005) Mitochondrial dysfunction and type 2 diabetes. Science 307: 384-387. (Pubitemid 40139974)
63. Hawley JA, Lessard SJ (2007) Mitochondrial function: use it or lose it. Diabetologia 50: 699-702. (Pubitemid 46355831)
64. Fingar DC, Salama S, Tsou C, Harlow E, Blenis J (2002) Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev 16: 1472-1487. (Pubitemid 34686329)
65. King TD, Song L, Jope RS (2006) AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3. Biochem Pharmacol 71: 1637-1647.
66. Asano T, Fujishiro M, Kushiyama A, Nakatsu Y, Yoneda M, et al. (2007) Role of phosphatidylinositol 3-kinase activation on insulin action and its alteration in diabetic conditions. Biol Pharm Bull 30: 1610-1616. (Pubitemid 47403232)
67. Ritov VB, Menshikova EV, Azuma K, Wood R, Toledo FGS, et al. (2010) Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity. Am J Physiol 298: E49-58.
68. Fröjdö S, Cozzone D, Vidal H, Pirola L (2007) Resveratrol is a class IA phosphoinositide 3-kinase inhibitor. Biochem J 406: 511-518. (Pubitemid 47425457)
69. Minakawa M, Kawano A, Miura Y, Yagasaki K (2011) Hypoglycemic effect of resveratrol in type 2 diabetic model db/db mice and its actions in cultured L6 myotubes and RIN-5F pancreatic b-cells. J Clin Biochem Nutr 48: 237-244.
70. Bass TM, Weinkove D, Houthoofd K, Gems D, Partridge L (2007) Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech Ageing Dev 128: 546-52. (Pubitemid 47498522)
71. Abbas S, Wink M (2009) Epigallocatechin gallate from green tea (Camellia sinensis) increases lifespan and stress resistance in Caenorhabditis elegans. Planta Med 75: 216-21.
72. Onken B, Driscoll M (2010) Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1 PLoS One 5: e8758.
73. Blander G, Guarente L (2004) The Sir2 family of protein deacetylases. Annu Rev Biochem 73: 417-435. (Pubitemid 39050375)
74. Hekimi S, Guarente L (2003) Genetics and the specificity of the aging process. Science 299: 1351-1354. (Pubitemid 36254640)